SOCS1 and inflammatory bowel disease: SOCS1 instigates several mechanisms for the suppression of cytokine production and is known to play a crucial role in the negative regulation of the TLR pathway during the development of IBD, making it a potential target for the treatment of inflammatory diseases involving hyper-cytokine signaling51,52.